- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05400421
Validation of Optical Device for Aortic Pulse Wave Velocity Measurement
June 1, 2022 updated by: VitalSines International Inc.
Validation of Photoplethysmography Device for the Measurement of Aortic Pulse Wave Velocity Against Carotid-Femoral Values From Piezoelectric Sensors
Existing techniques available for capturing reliable aortic pulse wave velocity measurements and estimating aortic stiffness are costly and require technical expertise.
The purpose of this research is to investigate an oximeter device performance as a stand-alone aortic pulse wave velocity (PWV) measurement instrument.
By validating this device and its measurements against the gold-standard method of carotid-femoral readings, we aim to demonstrate that the proposed method is an comparably effective in terms of the metrics (Mean difference, standard deviation, correlation, etc.) outlined by the Artery Society Guidelines.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
180
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jess Goodman, M.D.
- Phone Number: 416-670-9306
- Email: jess@goiheart.com
Study Contact Backup
- Name: Clare Wei
- Phone Number: 289-338-5669
- Email: c53wei@uwaterloo.ca
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Primary care clinic patients with a health cardiovascular background.
Description
Inclusion Criteria:
-
Exclusion Criteria:
- History of cardiovascular disease
- Not in sinus rhythm/arrhythmia
- Pacemaker
- Impalpable arterial pulse
- Use of blood pressure medication
- Systolic blood pressure > 140
- Use of vasoactive medication
- Use of cholesterol medication
- Diabetes diagnosis
- Smokers
- BMI > 30 kg/m2
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Device Calibration & Algorithm Training
The data obtained from this group will be used to a) quantify the relationship between PWV measured at the groin versus the thigh for less intrusive future piezo sensor placement and b) train the proposed device for the next cohort.
|
Carotid-femoral aortic pulse wave velocity will be compared against values collected from the oximeter system.
The former is assessed by placing piezoelectric pressure sensors at three locations: the right common carotid artery, the right common femoral artery (groin), and the right superficial femoral artery (thigh).
The oximeter will be secured on the right index finger.
Simultaneous data collection will occur for both methods, with each trail lasting 60 seconds.
|
Device & Algorithm Testing
The gold-standard and new device values will be collected from this group to validate the previously trained system.
|
Carotid-femoral aortic pulse wave velocity will be compared against values collected from the oximeter system.
The former is assessed by placing piezoelectric pressure sensors at three locations: the right common carotid artery, the right common femoral artery (groin), and the right superficial femoral artery (thigh).
The oximeter will be secured on the right index finger.
Simultaneous data collection will occur for both methods, with each trail lasting 60 seconds.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Aortic Pulse Wave Velocity
Time Frame: 6 measurements per subject, each lasting 60 seconds
|
The speed at which a single pulse/heart beat propagates down the aorta.
|
6 measurements per subject, each lasting 60 seconds
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jess Goodman, M.D., VitalSines International Inc.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003 Jun 10;107(22):2864-9. doi: 10.1161/01.CIR.0000069826.36125.B4. No abstract available.
- Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, Filipovsky J, Huybrechts S, Mattace-Raso FU, Protogerou AD, Schillaci G, Segers P, Vermeersch S, Weber T; Artery Society; European Society of Hypertension Working Group on Vascular Structure and Function; European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012 Mar;30(3):445-8. doi: 10.1097/HJH.0b013e32834fa8b0.
- Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, Boutouyrie P. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003 May;34(5):1203-6. doi: 10.1161/01.STR.0000065428.03209.64. Epub 2003 Apr 3.
- Xu SK, Hong XF, Cheng YB, Liu CY, Li Y, Yin B, Wang JG. Validation of a Piezoelectric Sensor Array-Based Device for Measurement of Carotid-Femoral Pulse Wave Velocity: The Philips Prototype. Pulse (Basel). 2018 Mar;5(1-4):161-168. doi: 10.1159/000486317. Epub 2018 Feb 8.
- Kelly R, Hayward C, Avolio A, O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation. 1989 Dec;80(6):1652-9. doi: 10.1161/01.cir.80.6.1652.
- Chirinos JA, Segers P, Duprez DA, Brumback L, Bluemke DA, Zamani P, Kronmal R, Vaidya D, Ouyang P, Townsend RR, Jacobs DR Jr. Late systolic central hypertension as a predictor of incident heart failure: the Multi-ethnic Study of Atherosclerosis. J Am Heart Assoc. 2015 Mar 3;4(3):e001335. doi: 10.1161/JAHA.114.001335.
- Ding FH, Fan WX, Zhang RY, Zhang Q, Li Y, Wang JG. Validation of the noninvasive assessment of central blood pressure by the SphygmoCor and Omron devices against the invasive catheter measurement. Am J Hypertens. 2011 Dec;24(12):1306-11. doi: 10.1038/ajh.2011.145. Epub 2011 Oct 6.
- Pereira T, Maldonado J, Coutinho R, Cardoso E, Laranjeiro M, Andrade I, Conde J. Invasive validation of the Complior Analyse in the assessment of central artery pressure curves: a methodological study. Blood Press Monit. 2014 Oct;19(5):280-7. doi: 10.1097/MBP.0000000000000058.
- Wang TW, Lin SF. Wearable Piezoelectric-Based System for Continuous Beat-to-Beat Blood Pressure Measurement. Sensors (Basel). 2020 Feb 5;20(3):851. doi: 10.3390/s20030851.
- Park J, Seok HS, Kim SS, Shin H. Photoplethysmogram Analysis and Applications: An Integrative Review. Front Physiol. 2022 Mar 1;12:808451. doi: 10.3389/fphys.2021.808451. eCollection 2021.
- I.B. Wilkinson, C.M. McEniery, G. Schillaci, P. Boutouyrie, P. Segers, A. Donald, et al. ARTERY Society guidelines for validation of non-invasive haemodynamic measurement devices: part 1, arterial pulse wave velocity Artery Res, 4 (2) (2010), p. 34
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
June 1, 2022
Primary Completion (Anticipated)
July 1, 2022
Study Completion (Anticipated)
July 1, 2022
Study Registration Dates
First Submitted
May 27, 2022
First Submitted That Met QC Criteria
May 27, 2022
First Posted (Actual)
June 1, 2022
Study Record Updates
Last Update Posted (Actual)
June 6, 2022
Last Update Submitted That Met QC Criteria
June 1, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- OBA-MAPWV
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Pulse Wave Velocity
-
Instituto de Cardiologia do Rio Grande do SulUnknownObesity | Overweight | Glycemic Index | Pulse Wave Velocity
-
Centro Hospitalar de Lisboa CentralBaylor College of Medicine; Children's Hospital Colorado; Boston Children's Hospital and other collaboratorsUnknownAortic Coarctation | Functional Magnetic Resonance Imaging | Arterial Stiffness | Vascular Endothelium | PULSE WAVE VELOCITYPortugal
-
China Medical University HospitalRecruiting
-
Northern State Medical UniversityCompletedPulse Wave AnalysisRussian Federation
-
University of LeicesterBritish Heart FoundationCompletedAbdominal Aortic Aneurysm | Pulse Wave Analysis | RiskUnited Kingdom
-
University of California, San DiegoCompletedHypertension | Prehypertension | Gout | Pulse Wave Velocity | 24 Hour Blood PressureUnited States
-
Shin Kong Wu Ho-Su Memorial HospitalRecruitingIschemic Stroke | Rehabilitation | Arterial Stiffness | Pulse Wave VelocityTaiwan
-
University Hospital Schleswig-HolsteinCompletedHemodynamics | Surgery in Elderly Patients | Pulse Wave Transit TimeGermany
-
Academisch Ziekenhuis MaastrichtEuropean Foundation for the Study of DiabetesCompletedDiabetes Mellitus | Physical Activity | Sedentary Lifestyle | Type2 Diabetes | Aortic Stiffness | Arterial Stiffness | Physical Exercise | Pulse Wave Velocity | Light Intensity Physical Activity | Artery DiseaseNetherlands
-
Chinese Academy of Medical Sciences, Fuwai HospitalRecruitingBlood Pressure | Pulse Wave Analysis | Ankle Brachial Index | Patient Outcome AssessmentChina
Clinical Trials on System & Method for Monitoring Aortic Pulse Wave Velocity & Blood Pressure
-
Hospices Civils de LyonCompletedShort Bowel Syndrome | Hyperoxaluria | HyperoxalemiaFrance
-
Centre Hospitalier Universitaire de NīmesCompletedBlood Pressure Disorders | Pregnancy Induced HypertensionFrance
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteRecruiting
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; The Association...RecruitingCovid19 | Endothelial Dysfunction | Diastolic Dysfunction | Arterial StiffnessFrance
-
Grupo Español de Rehabilitación MultimodalUnknownSurgery | Perioperative/Postoperative Complications | Exercise ToleranceSpain
-
Arno Schmidt-TrucksässRecruitingDepression | Burnout | Stress Related DisorderSwitzerland
-
Aktiia SANot yet recruiting
-
VA Office of Research and DevelopmentCompletedInflammation | Cardiovascular Disease | Atherosclerosis | Chronic Kidney Disease | Aortic StiffnessUnited States
-
University of FloridaAmerican Society of NephrologyWithdrawnHypertension | Chronic Kidney Disease | Acute Kidney InjuryUnited States
-
Central Hospital, Nancy, FranceCompleted